Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth
- PMID: 25868136
- PMCID: PMC4396681
- DOI: 10.1097/OLQ.0000000000000264
Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth
Abstract
Background: Little is known about the epidemiology or risk factors for oral human papillomavirus (HPV) in HIV-infected youth. The objectives of this study were to determine the prevalence and correlates of oral HPV infection and to explore the association between HPV vaccination and oral infection in HIV-infected youth.
Methods: Youth 12 to 24 years of age with behaviorally acquired HIV were recruited for this cross-sectional study. Procedures involved medical chart review, survey, and collection of an oral rinse sample. Univariable and multivariable logistic regression models were used to determine whether demographic, behavioral, immunologic, and virologic factors and history of vaccination were significantly associated with oral HPV infection.
Results: Mean age of the 272 participants was 21.5 years; 64% were non-Hispanic black and 20.2% were Hispanic; and 10.8% of men compared with 20.3% of women were fully vaccinated. Human papillomavirus prevalence was 19.7% in men and 18.6% in women (P = 1.0). Only men were positive for vaccine-type HPV: 5.6% were positive for HPV-6, HPV-11, HPV-16, and/or HPV-18, and 4.2% were positive for HPV-16 and/or HPV-18. Among men who were fully vaccinated, none were positive for HPV-6, HPV-11, HPV-16, and/or HPV-18, compared with 12 (6.3%) of men who were not fully vaccinated (P = 0.37). Two variables were marginally associated with oral HPV (P < 0.10): marijuana use in the previous 3 months and lower CD4+ T-cell count.
Conclusions: Prevalence rates of oral HPV were relatively high in this population of HIV-infected youth and were similar in male and female youth. No fully vaccinated men were infected with vaccine-type HPV.
Similar articles
-
Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.J Med Virol. 2016 Nov;88(11):1944-52. doi: 10.1002/jmv.24555. Epub 2016 May 9. J Med Virol. 2016. PMID: 27096166 Free PMC article.
-
Prevalence and determinants of oral infection by Human Papillomavirus in HIV-infected and uninfected men who have sex with men.PLoS One. 2017 Sep 14;12(9):e0184623. doi: 10.1371/journal.pone.0184623. eCollection 2017. PLoS One. 2017. PMID: 28910359 Free PMC article.
-
Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.Sex Transm Dis. 2018 Oct;45(10):660-665. doi: 10.1097/OLQ.0000000000000845. Sex Transm Dis. 2018. PMID: 30204745 Free PMC article.
-
National prevalence of oral HPV infection and related risk factors in the U.S. adult population.Oral Dis. 2012 Jul;18(5):430-41. doi: 10.1111/j.1601-0825.2011.01892.x. Epub 2012 Jan 18. Oral Dis. 2012. PMID: 22251072 Review.
-
The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature.BMC Infect Dis. 2016 Jun 14;16:293. doi: 10.1186/s12879-016-1633-9. BMC Infect Dis. 2016. PMID: 27301867 Free PMC article. Review.
Cited by
-
[Recurrent laryngeal papillomatosis].HNO. 2023 Feb;71(2):77-82. doi: 10.1007/s00106-022-01250-1. Epub 2022 Dec 7. HNO. 2023. PMID: 36477391 Free PMC article. Review. German.
-
Human Papillomavirus-Associated Oropharyngeal Cancer: Global Epidemiology and Public Policy Implications.Cancers (Basel). 2023 Aug 13;15(16):4080. doi: 10.3390/cancers15164080. Cancers (Basel). 2023. PMID: 37627108 Free PMC article. Review.
-
Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.J Med Virol. 2016 Nov;88(11):1944-52. doi: 10.1002/jmv.24555. Epub 2016 May 9. J Med Virol. 2016. PMID: 27096166 Free PMC article.
-
Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.BMC Med. 2018 Jul 18;16(1):110. doi: 10.1186/s12916-018-1098-3. BMC Med. 2018. PMID: 30016957 Free PMC article. Review.
-
Oral Human Papillomavirus in Youth From the Pediatric HIV/AIDS Cohort Study.Sex Transm Dis. 2016 Aug;43(8):498-500. doi: 10.1097/OLQ.0000000000000495. Sex Transm Dis. 2016. PMID: 27414680 Free PMC article.
References
-
- Xea Castellsague., editor. HPV and Cervical Cancer in the World 2007. Report. Vaccine. 2007;25(Suppl 3):C1–230. - PubMed
-
- Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine. 2003;348:518–527. - PubMed
-
- Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772–1783. - PubMed
-
- D'Souza G, Fakhry C, Sugar EA, Seaberg EC, Weber K, Minkoff HL, et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer. 2007;121:143–150. - PubMed
-
- Gillison ML, Lowy DR. A causal role for human papillomavirus in head and neck cancer. Lancet. 2004;363:1488–1489. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials